TRACON Pharmaceuticals is an American company that develops cancer-fighting drugs for commercial purposes. The firm has several products in the clinical stage, including a single-domain antibody and a monoclonal antibody. TRACON Pharmaceuticals collaborates with institutions such as the National Cancer Institute and licenses its products to other firms.